Key features of HCC1319:

• Origin: HCC1319 cells were derived from a human breast carcinoma. Like many breast cancer cell lines, they provide researchers with a model system to study cancer biology in vitro.

• Subtype: HCC1319 is classified as HER2-positive, meaning it overexpresses the HER2 (human epidermal growth factor receptor 2) protein. This makes it particularly relevant for research into HER2-targeted therapies like trastuzumab (Herceptin).

• Research Applications: The HCC1319 cell line is commonly used in cancer research to study:

  • Tumor progression and metastasis

  • Drug resistance in breast cancer therapies

  • Gene expression related to HER2 signaling pathways

  • Therapeutic development for HER2-positive breast cancer

  
  

These cells have been employed to assess the efficacy of drugs and therapies targeting specific pathways in HER2-positive breast cancer. Additionally, HCC1319 may be used in studies related to understanding the molecular mechanisms behind HER2 activation and the subsequent cellular responses.